A blog bringing you perspectives from the frontlines of the drug pricing debate.
This fall, CAPD released a groundbreaking new poll showing that employers strongly value their PBMs. By high margins,…
New research out today from CAPD, conducted by Hart Research Associates, shows how strongly union households value their…
GOP candidates will soon take the stage for one of the biggest political moments of the year: the…
It’s hard to miss the recent headlines about new weight-loss drugs like Ozempic and Wegovy. Called GLP-1s, these…
Over the last twenty years, new medications have dramatically changed the fight against HIV/AIDS. These medications – called…
We took note of two recent POLITICO articles that make very, very clear the reality of what’s going…
Rhetoric in Washington, DC around high and rising drug prices continues to intensify. As Congress considers potential legislation,…
Although Congress has devoted much attention to exploring pharmaceutical manufacturers and pharmacy benefit managers, less attention has been…
As Congress continues to examine the drug supply chain and how to lower prescription drug prices for Americans,…
As Congress returns for a new work period, both parties are renewing their focus on how to bring…
